questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Aurora kinases
Aurora kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Kinases Aurora
Diagnostic médical
Marqueurs tumoraux
Kinases Aurora
Cancer du sein
Kinases Aurora
Phosphorylation
Kinases Aurora
Analyse sanguine
Kinases Aurora
Symptômes
5
Symptômes du cancer
Kinases Aurora
Division cellulaire
Kinases Aurora
Signes précoces de cancer
Kinases Aurora
Symptômes neurologiques
Kinases Aurora
Croissance tumorale
Kinases Aurora
Prévention
5
Prévention du cancer
Kinases Aurora
Dépistage du cancer
Kinases Aurora
Mode de vie sain
Kinases Aurora
Antioxydants
Kinases Aurora
Vaccination
Kinases Aurora
Traitements
5
Inhibiteurs de kinases
Kinases Aurora
Efficacité des traitements
Kinases Aurora
Effets secondaires
Kinases Aurora
Chimiothérapie
Kinases Aurora
Essais cliniques
Kinases Aurora
Complications
5
Complications du cancer
Kinases Aurora
Métastases
Kinases Aurora
Pronostic du cancer
Kinases Aurora
Complications des traitements
Kinases Aurora
Réponse immunitaire
Kinases Aurora
Facteurs de risque
5
Facteurs de risque
Kinases Aurora
Alimentation
Kinases Aurora
Infections virales
Kinases Aurora
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aurora kinases : Questions médicales les plus fréquentes",
"headline": "Aurora kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aurora kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-30",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aurora kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protein-Serine-Threonine Kinases",
"url": "https://questionsmedicales.fr/mesh/D017346",
"about": {
"@type": "MedicalCondition",
"name": "Protein-Serine-Threonine Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017346",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aurora kinase A",
"alternateName": "Aurora Kinase A",
"url": "https://questionsmedicales.fr/mesh/D064096",
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinase A",
"code": {
"@type": "MedicalCode",
"code": "D064096",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.103.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aurora kinase B",
"alternateName": "Aurora Kinase B",
"url": "https://questionsmedicales.fr/mesh/D064107",
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinase B",
"code": {
"@type": "MedicalCode",
"code": "D064107",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.103.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aurora kinase C",
"alternateName": "Aurora Kinase C",
"url": "https://questionsmedicales.fr/mesh/D064108",
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinase C",
"code": {
"@type": "MedicalCode",
"code": "D064108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.103.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinases",
"alternateName": "Aurora Kinases",
"code": {
"@type": "MedicalCode",
"code": "D064127",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Karen Schindler",
"url": "https://questionsmedicales.fr/author/Karen%20Schindler",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA."
}
},
{
"@type": "Person",
"name": "Cecilia S Blengini",
"url": "https://questionsmedicales.fr/author/Cecilia%20S%20Blengini",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics; Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America."
}
},
{
"@type": "Person",
"name": "Mansour Aboelenain",
"url": "https://questionsmedicales.fr/author/Mansour%20Aboelenain",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA."
}
},
{
"@type": "Person",
"name": "Jing Wang",
"url": "https://questionsmedicales.fr/author/Jing%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, the First Affiliated Hospital of Gannan Medical College, Ganzhou, China."
}
},
{
"@type": "Person",
"name": "Tao Guo",
"url": "https://questionsmedicales.fr/author/Tao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Influence of Probiotics Consumption on Management of Prediabetic State: A Systematic Review of Clinical Trials.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36160290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/5963679"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trends and disparities in diabetes and prediabetes among adults in the United States, 1999-2018.",
"datePublished": "2022-12-29",
"url": "https://questionsmedicales.fr/article/36586345",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.puhe.2022.10.021"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuropathy in prediabetes.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37470302",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/dmrr.3693"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prediabetes and skeletal health.",
"datePublished": "2023-05-29",
"url": "https://questionsmedicales.fr/article/37248797",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MED.0000000000000812"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perspectives on Prediabetes and Aging.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36948785",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ecl.2022.10.011"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aurora kinases",
"item": "https://questionsmedicales.fr/mesh/D064127"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aurora kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aurora kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aurora kinases",
"description": "Comment diagnostiquer une anomalie des kinases Aurora ?\nQuels marqueurs sont associés aux kinases Aurora ?\nLes kinases Aurora sont-elles liées à des cancers spécifiques ?\nQuels tests sont utilisés pour évaluer l'activité des kinases Aurora ?\nPeut-on détecter les kinases Aurora dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Prediabetic+State#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aurora kinases",
"description": "Quels symptômes sont liés à une dysrégulation des kinases Aurora ?\nLes kinases Aurora affectent-elles la division cellulaire ?\nY a-t-il des signes précoces de cancer liés aux kinases Aurora ?\nLes kinases Aurora sont-elles impliquées dans des symptômes neurologiques ?\nComment les kinases Aurora influencent-elles la croissance tumorale ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Prediabetic+State#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aurora kinases",
"description": "Peut-on prévenir les anomalies des kinases Aurora ?\nLes dépistages réguliers aident-ils à détecter les problèmes liés aux kinases Aurora ?\nY a-t-il des facteurs de mode de vie influençant les kinases Aurora ?\nLes antioxydants aident-ils à prévenir les anomalies des kinases Aurora ?\nLes vaccinations peuvent-elles prévenir les cancers liés aux kinases Aurora ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Prediabetic+State#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aurora kinases",
"description": "Quels traitements ciblent les kinases Aurora ?\nLes inhibiteurs de kinases Aurora sont-ils efficaces ?\nQuels effets secondaires peuvent résulter des traitements ciblant les kinases Aurora ?\nLes traitements ciblant les kinases Aurora sont-ils combinés avec d'autres thérapies ?\nY a-t-il des essais cliniques sur les kinases Aurora ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Prediabetic+State#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aurora kinases",
"description": "Quelles complications peuvent survenir avec des anomalies des kinases Aurora ?\nLes anomalies des kinases Aurora augmentent-elles le risque de métastases ?\nComment les anomalies des kinases Aurora affectent-elles le pronostic ?\nLes complications des traitements ciblant les kinases Aurora sont-elles fréquentes ?\nLes anomalies des kinases Aurora peuvent-elles affecter la réponse immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Prediabetic+State#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aurora kinases",
"description": "Quels sont les facteurs de risque associés aux anomalies des kinases Aurora ?\nL'âge influence-t-il le risque d'anomalies des kinases Aurora ?\nLe tabagisme est-il un facteur de risque pour les kinases Aurora ?\nL'alimentation joue-t-elle un rôle dans les anomalies des kinases Aurora ?\nLes infections virales sont-elles liées aux anomalies des kinases Aurora ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Prediabetic+State#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des kinases Aurora ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de tissus tumoraux peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux kinases Aurora ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux d'expression des kinases Aurora A et B peuvent servir de marqueurs tumoraux."
}
},
{
"@type": "Question",
"name": "Les kinases Aurora sont-elles liées à des cancers spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent surexprimées dans des cancers comme le sein et le poumon."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des kinases Aurora ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de phosphorylation et des analyses de Western blot sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les kinases Aurora dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, la détection se fait principalement dans les tissus tumoraux, pas dans le sang."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysrégulation des kinases Aurora ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le cancer, mais peuvent inclure fatigue, douleur et perte de poids."
}
},
{
"@type": "Question",
"name": "Les kinases Aurora affectent-elles la division cellulaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles jouent un rôle clé dans la mitose, et leur dysfonction peut entraîner des anomalies cellulaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes précoces de cancer liés aux kinases Aurora ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes précoces peuvent inclure des changements inexpliqués dans le corps, mais sont souvent vagues."
}
},
{
"@type": "Question",
"name": "Les kinases Aurora sont-elles impliquées dans des symptômes neurologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les kinases Aurora et des troubles neurologiques dans certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les kinases Aurora influencent-elles la croissance tumorale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles régulent la mitose, et leur surexpression peut conduire à une croissance tumorale incontrôlée."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des kinases Aurora ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode spécifique, mais un mode de vie sain peut réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers aident-ils à détecter les problèmes liés aux kinases Aurora ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent aider à détecter des cancers associés aux anomalies des kinases."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de mode de vie influençant les kinases Aurora ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et l'exercice peuvent influencer la santé cellulaire et réduire les risques."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à prévenir les anomalies des kinases Aurora ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les antioxydants peuvent réduire le stress oxydatif, mais des recherches sont nécessaires."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir les cancers liés aux kinases Aurora ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancers spécifiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les kinases Aurora ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des kinases Aurora sont en développement pour traiter divers cancers."
}
},
{
"@type": "Question",
"name": "Les inhibiteurs de kinases Aurora sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent qu'ils peuvent réduire la croissance tumorale, mais des recherches sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent résulter des traitements ciblant les kinases Aurora ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue et troubles hématologiques."
}
},
{
"@type": "Question",
"name": "Les traitements ciblant les kinases Aurora sont-ils combinés avec d'autres thérapies ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent combinés avec la chimiothérapie ou la radiothérapie pour améliorer l'efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques sur les kinases Aurora ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent l'efficacité des inhibiteurs de kinases Aurora dans divers cancers."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des kinases Aurora ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la progression rapide du cancer et la résistance aux traitements."
}
},
{
"@type": "Question",
"name": "Les anomalies des kinases Aurora augmentent-elles le risque de métastases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surexpression des kinases Aurora est souvent associée à une augmentation des métastases."
}
},
{
"@type": "Question",
"name": "Comment les anomalies des kinases Aurora affectent-elles le pronostic ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont souvent liées à un pronostic défavorable en raison de la croissance tumorale agressive."
}
},
{
"@type": "Question",
"name": "Les complications des traitements ciblant les kinases Aurora sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme des infections et des troubles sanguins peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les anomalies des kinases Aurora peuvent-elles affecter la réponse immunitaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent altérer la réponse immunitaire, rendant le corps moins efficace contre le cancer."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque associés aux anomalies des kinases Aurora ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux de cancer, l'exposition à des agents cancérigènes."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anomalies des kinases Aurora ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'anomalies des kinases Aurora augmente généralement avec l'âge."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque pour les kinases Aurora ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour plusieurs types de cancer associés aux kinases."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les anomalies des kinases Aurora ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en graisses et en sucres peut augmenter le risque de cancer et d'anomalies."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles liées aux anomalies des kinases Aurora ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le HPV, sont associées à des cancers où les kinases Aurora sont impliquées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA.
Publications dans "Aurora kinases" :
3 publications dans cette catégorie
Affiliations :
Department of Genetics; Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America.
Human Genetics Institute of New Jersey; Piscataway, New Jersey, United States of America.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA.
Department of Theriogenology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, the First Affiliated Hospital of Gannan Medical College, Ganzhou, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China. liuq9@mail.sysu.edu.cn.
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China. liuq9@mail.sysu.edu.cn.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Chemistry and Quality Assurance, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai 400056, India.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Lanzhou University, Lanzhou 730000, China. Electronic address: chenshw@lzu.edu.cn.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Seton Hall University, South Orange, NJ, USA.
Department of Genetics, Rutgers University, Piscataway, NJ, USA.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratoire de Spectrométrie de Masse Protéomique, Institute Curie, PSL Research University, Paris, France.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratoire de Spectrométrie de Masse Protéomique, Institute Curie, PSL Research University, Paris, France.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institut de Génétique et Développement de Rennes (IGDR), Unité CNRS, UMR 6290, Université de Rennes, 35043, Rennes, France.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, All India Institute of Medical Sciences, Delhi 110029, India.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, All India Institute of Medical Sciences, Delhi 110029, India.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, All India Institute of Medical Sciences, Delhi 110029, India. Electronic address: punitkaur@aiims.edu.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, USA.
Publications dans "Aurora kinases" :
Prediabetes consists of the intermediary stage between normal glucose regulation and overt diabetes mellitus and develops when blood glucose levels are higher than normal but not high enough to confir...
The aims of the study were to describe the up-to-date trend of total, diagnosed, and undiagnosed diabetes and prediabetes, assess their associated disparities among population subgroups, and examine t...
This was a cross-sectional study from a nationally representative sample of US adults (aged ≥20 years) who participated in the National Health and Nutrition Examination Survey....
Diagnosed diabetes was defined as a self-reported previous diagnosis of diabetes by a physician or any other health professionals (other than during pregnancy). Undiagnosed diabetes was defined as ele...
A total of 21,600 (mean, 47.2 years [SD, 14.7]) individuals were analyzed. From 1999 to 2018, the age-standardized prevalence increased significantly from 9.17% to 14.7% (difference, 5.52%; 95% confid...
The prevalence of diabetes and prediabetes increased significantly from 1999 to 2018 among US adults. There are substantial and persistent disparities among racial and ethnic minorities, populations e...
Diabetic neuropathies are the most frequent complications of diabetes, contributing to high morbidity, excess mortality, reduced quality of life, and increased healthcare costs. Prediabetes is charact...
Type 2 diabetes mellitus (T2D) confers a greater risk of skeletal fragility and fracture. Whether prediabetes is detrimental to bone health is uncertain....
We summarize the current data on the associations of prediabetes with bone turnover, bone mineral density, bone quality, bone material properties and fracture risk....
In cross-sectional studies, prediabetes was associated with lower bone turnover and worse trabecular bone quality. A longitudinal analysis showed that larger increase in insulin resistance (in the abs...
Diabetes prevention programs (DPPs) have been shown to effectively delay, and sometimes prevent, the progression from prediabetes to diabetes; however, labeling someone with prediabetes comes with pot...
To estimate the prevalence of prediabetes and to assess the association of prediabetic stages with sociodemographic, lifestyle and clinical factors DESIGN: Cross-sectional study at the screening and i...
A total of 6222 residents of two study sites, aged 18-64 years and without a history of diabetes, were eligible for prediabetes screening. Exclusion criteria were pregnancy, history of diabetes and cr...
Prevalence of prediabetes based on glycated haemoglobin (HbA1c) criteria (5.7%-6.4%) was the primary outcome of the study. Odds Ratio and 95% CI were estimated to assess the associations between the o...
Out of 6222 screened participants, 308 (5%, 95% CI: 4.4% to 5.5%) individuals were detected with prediabetes based on HbA1c. The mean age of 291 responded participants was 50.3±7.6 years and 67% were ...
The estimated prevalence of prediabetes was 5% among screened participants, and female gender was associated with the prediabetic stage. As a large proportion of the population with prediabetes were n...
NCT04074148, 2019/783....
Prediabetes is characterized by abnormal glycemic levels below the type 2 diabetes threshold, and effective control of blood glucose may prevent the progression to type 2 diabetes. While the associati...
India is witnessing an epidemic of type 2 diabetes. Overweight/obesity, overnutrition, physical inactivity, and family history are well-known risk factors for diabetes. We investigated the role of und...
DERVAN cohort study was set up in the KONKAN region of the western Indian state of Maharashtra. It enrolled 1,520 adolescent girls (16-18 years old at the time of enrollment). We measured glycemic par...
The median age of the subjects was 16.6 years. The median weight, height, and BMI were 40.7 kg, 151.7 cm, and 17.5 kg/m...
We have reported a high prevalence of prediabetes among rural adolescent girls with a very low prevalence of obesity. Prediabetes in obesity is driven by hyperinsulinemia and overworking of the pancre...
Type II diabetes mellitus is a chronic medical condition affecting societies worldwide. The duration of hyperglycemia is a strong predictor of adverse outcomes and imposes immense clinical and public ...
Patients at a large urban academic medical center were not consistently identified as having a high risk of hyperglycemia....
The project used a pretest-posttest design. Retrospective data on new-onset hyperglycemia incidence were compared for all individuals seeking primary care services 6 weeks before and after the interve...
Patients without a known hyperglycemia history were provided the screening tool to determine risk status. Additional screening measures were implemented for patients identified as high risk on the ini...
A total of 52 (61.6%) of the 84 individuals who met inclusion criteria during the intervention period were diagnosed with new-onset chronic hyperglycemia. In contrast, 20 (22.5%) of the 89 individuals...
A diabetes risk assessment tool is quick and reliable in capturing high-risk individuals who would benefit from additional screening measures....
Neuropathic pain is associated with several clinical conditions, including anxiety, depression, sleep disorders, and decreased quality of life; however, less evaluated in prediabetes. This study aims ...
One hundred and seventy-two patients with prediabetes and 170 controls were included in this cross-sectional study. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale and Douleu...
Twenty-three (13.4%) and 12 (7%) patients with prediabetes were diagnosed with neuropathic pain using DN4 and LANSS questionnaires, respectively. Neuropathic pain rates of the patients were higher tha...
Neuropathic pain was increased in prediabetes by DN4 and LANNS questionnaires. An appropriate diagnosis of neuropathic pain in prediabetes may prevent patients from different pain-related clinical con...